Medindia

X

Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast

Friday, September 18, 2009 General News J E 4
Advertisement


OMAHA, Neb., Aug. 12 Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

To access the call via telephone, call 800-894-5910 or 785-424-1052. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, August 26, 2009. To access, dial 800-388-9064 or 402-220-1116.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE((R)) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.

What: Transgenomic Inc. Second Quarter 2009 Earnings Release Conference Call When: Wednesday, August 12, 2009 @ 5:00 p.m. Eastern Where: http://www.transgenomic.com/events.asp?id=6 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Investor Relations, 402-452-5400

SOURCE Transgenomic Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
VetCentric Partners with Elanco Animal Health
S
International Isotopes Inc. Announces Second Quart...